This work provides a proof-of-concept for the use of the extra-cellular domain of Ov58GPCR as well as its peptide cocktails in monitoring the efficacy of ivermectin chemotherapeutic programs for onchocerciasis and for the detection of new infections based on antigen-specific IgE responses. Here, IGHE is linked to onchocerciasis.